Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Interest Expenses (2016 - 2017)

Updated

Avenue Therapeutics (ATXI) posted Interest Expenses of $294,000 for FY2017, down 30.0% from $420,000 in FY2016.

Analysis

Avenue Therapeutics (ATXI) Interest Expenses (2016 - 2017) Analysis & Trends

  • Business Quant data shows ATXI's Interest Expenses at $420,000 in FY2016 (+95.3%) and $215,000 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 217.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 247.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 106,000.00
Jun 30, 2017 93,000.00
Mar 31, 2017 95,000.00
Dec 31, 2016 159,000.00
Sep 30, 2016 89,000.00
Jun 30, 2016 87,000.00
Mar 31, 2016 85,000.00
API Access

Avenue Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ATXI&period=max&api_key=YOUR_API_KEY